SCHEMBL7019255

SCHEMBL7019255

Cc1ccc(-c2ccc(-c3noc(C(Cl)(Cl)Cl)n3)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.54
NPC1 O15118 12/20 0.51
RAB9A P51151 11/20 0.51
NFKB1 P19838 4/20 0.51
NFKB2 Q00653 4/20 0.51
RELA Q04206 4/20 0.51
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
HDAC4 P56524 3/20 0.48
HDAC6 Q9UBN7 2/20 0.48
HDAC1 Q13547 1/20 0.48
SMN1; SMN2 Q16637 9/20 0.47
MAPT P10636 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
CASP3 P42574 2/20 0.47
L3MBTL1 Q9Y468 5/20 0.46
TP53 P04637 2/20 0.45
MAPK1 P28482 2/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4227737 0.98 NR1H4 (0.56) NR1H4NPC1RAB9ANFKB1NFKB2
SCHEMBL7014203 0.88 L3MBTL1 (0.51) NR1H4NPC1RAB9ANFKB1NFKB2
SCHEMBL26968024 0.85 HDAC4 (0.53) NR1H4NPC1RAB9ANFKB1NFKB2
SCHEMBL6609615 0.83 NPC1 (0.47) NR1H4NPC1RAB9ANFKB1NFKB2
SCHEMBL31375602 0.82 NPC1 (0.54) NR1H4NPC1RAB9ANFKB1NFKB2
SCHEMBL17377373 0.82 NOTUM (0.53) NR1H4NPC1RAB9AKMT2AHDAC4
SCHEMBL18608950 0.81 HDAC4 (0.67) NPC1RAB9AHDAC4HDAC6HDAC1
SCHEMBL3634573 0.80 NR1H4 (0.57) NR1H4NPC1RAB9ANFKB1NFKB2
SCHEMBL11920077 0.79 NR1H4 (0.50) NR1H4NPC1RAB9ANFKB1NFKB2
SCHEMBL7018023 0.79 HDAC6 (0.43) HDAC4HDAC6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0520423-B1 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-05-14 EP disclosed
US-6100252-A SPECIFIED COMPOUNDS INCLUDING METHYL 2-BUTYL-1-((2'-(2-OXO-3H-1,2,3,5-OXATHIADIAZOL-4-YL)BIPHENYL) METHYL)-BENZIMIDAZOLE-7-CARBOXYLATE; USE TO TREAT CIRCULATORY DISEASES SUCH AS HYPERTENSIVE DISEASES AND HEART DISEASES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-08 US disclosed
US-5883111-A STRONG AND LONG-LASTING ACTION BY ORAL ADMINISTRATION; HYPOTENSIVE AGENTS; CARDIOTONIC AGENTS; ALZHEIMER'S DISEASE; TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-03-16 US disclosed
US-5583141-A ADMINISTERING AS THERAPEUTIC AGENTS OF CIRCULATORY DISEASES; AZILSARTAN; ANGIOTENSIN II ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-12-10 US disclosed
US-5354766-A 2-Ethoxy-1-((2'(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl) biphenyl-4-yl)methyl)benzimidazole-7-carboxylic acid; hypotensive agents; CNS activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-10-11 US disclosed
US-5243054-A Hypotensive agents, cardiovascular disorders or nervous system disorders TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-09-07 US disclosed
EP-0520423-A2 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-30 EP disclosed